Tirzepatide is a groundbreaking therapeutic agent for individuals facing type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://kaitlynhioa086291.getblogs.net/73116603/tirzepatide-a-game-changer-for-type-2-diabetes